A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents
Condition: Migraine Disorders Interventions: Drug: Ketorolac; Drug: Metoclopramide; Device: Active Remote Electrical Neuromodulation Device; Drug: Placebo; Device: Sham Remote Electrical Neuromodulation Device Sponsor: University of Calgary Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Children | Clinical Trials | Headache | Metoclopramide | Migraine | Neurology | Research